CNY 4.3
(-2.49%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 243.96 Million | 1.17 Billion | 42.44 Million | -114.25 Million | -128.31 Million | 739.73 Million |
Net Income | 31.97 Million | 317.54 Million | -8.02 Million | -863.18 Million | -786.5 Million | 390.27 Million |
Depreciation & Amortization | 460.91 Million | 422.96 Million | 382.92 Million | 368.82 Million | 400.64 Million | 425.33 Million |
Deferred income taxes | -5.16 Million | -12.41 Million | 32.16 Million | -4.58 Million | -3.31 Million | -20.9 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -642.55 Million | 114.01 Million | -308.14 Million | -114.37 Million | -597.11 Million | -497.58 Million |
Other non-cash items | 1.96 Billion | 325.43 Million | -24.31 Million | 494.47 Million | 854.66 Million | 421.7 Million |
Investing Cash Flow | -334.84 Million | -63.91 Million | 619.15 Million | -359.74 Million | -141.03 Million | -23.58 Million |
Investments in PPE | -391.49 Million | -99.18 Million | -64.42 Million | -7.33 Million | -141.13 Million | -26.89 Million |
Acquisitions | 56.65 Million | 14.31 Million | - | -19.43 Million | 141.9 Million | 29.69 Million |
Investment purchases | - | -14.31 Million | -423.09 Thousand | -469.33 Million | -2.45 Million | -278.95 Thousand |
Sales/Maturities of investments | - | 20.95 Million | 37.51 Million | 72.62 Million | 1.78 Million | 798.23 Thousand |
Other Investing Activities | 1.00 | 14.31 Million | 646.49 Million | 63.73 Million | -141.13 Million | -26.89 Million |
Financing Cash Flow | -185.11 Million | -630.73 Million | -458.18 Million | -380.75 Million | -24.68 Million | -157.98 Million |
Debt repayment | -339.85 Million | -3.06 Billion | -2.96 Billion | -3.16 Billion | -2.67 Billion | -3.48 Billion |
Dividends payments | -196.61 Million | -202.16 Million | -242.34 Million | -308.91 Million | -50.76 Million | -308.57 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 154.73 Million | 2.63 Billion | 2.75 Billion | 3.09 Billion | 2.99 Billion | 3.63 Billion |
Accounts receivables | -164.2 Million | 315.13 Million | 221.68 Million | -104.5 Million | 23.84 Million | -208.21 Million |
Accounts payables | -528.25 Million | -271.7 Million | -775.72 Million | 78.15 Million | -518.15 Million | -208.21 Million |
Inventory | 49.89 Million | 82.99 Million | 213.72 Million | -83.45 Million | -105.22 Million | 67.26 Million |
Other working capital | -533.41 Million | -12.41 Million | 32.16 Million | -4.58 Million | 2.41 Million | -564.85 Million |
Cash at beginning of period | 3.81 Billion | 611.72 Million | 408.31 Million | 1.26 Billion | 1.55 Billion | 997.94 Million |
Cash at end of period | 2.74 Billion | 1.09 Billion | 611.72 Million | 408.31 Million | 1.26 Billion | 1.55 Billion |
Capital Expenditure | -391.49 Million | -99.18 Million | -64.42 Million | -7.33 Million | -141.13 Million | -26.89 Million |
Effect of forex changes on cash | -798.78 Million | - | - | 0.34 | - | - |
Net cash flow / Change in cash | -1.07 Billion | 485.31 Million | 203.41 Million | -854.76 Million | -294.03 Million | 558.16 Million |
Free Cash Flow | -147.52 Million | 1.08 Billion | -21.98 Million | -121.59 Million | -269.45 Million | 712.83 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.62 Million | -23.44 Million | 33.82 Million | 31.97 Million | 130.21 Million | -144.7 Million |
Depreciation & Amortization | - | 125.31 Million | - | 460.91 Million | 114.94 Million | 114.94 Million |
Deferred income taxes | - | - | - | -5.16 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -642.55 Million | -114.3 Million | - |
Other non-cash items | 117.41 Million | -34.51 Million | 110.17 Million | 1.96 Billion | -34.47 Million | -41.97 Million |
Investing Cash Flow | -37.42 Million | -56.52 Million | -60.5 Million | -334.84 Million | -113.85 Million | -113.46 Million |
Investments in PPE | -135.77 Million | -120.62 Million | -78.35 Million | -391.49 Million | -130.14 Million | -113.46 Million |
Acquisitions | 990.07 Thousand | 1.59 Million | 17.84 Million | 56.65 Million | 16.29 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 97.35 Million | 62.5 Million | 17.84 Million | 1.00 | 1.00 | - |
Financing Cash Flow | 198.68 Million | -103.61 Million | -89.4 Million | -185.11 Million | 159.24 Million | -78.1 Million |
Debt repayment | -299.9 Million | -121 Million | -99.9 Million | -339.85 Million | -211 Million | -325.1 Million |
Dividends payments | -39.65 Million | -42 Million | -66.63 Million | -196.61 Million | -37.63 Million | -52.44 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -61.56 Million | -177.18 Million | -122.66 Million | 154.73 Million | 370.24 Million | 299.43 Million |
Accounts receivables | - | - | - | -164.2 Million | -164.2 Million | - |
Accounts payables | - | - | - | -528.25 Million | - | - |
Inventory | - | - | - | 49.89 Million | 49.89 Million | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 722.36 Million | 815.13 Million | 821.04 Million | 3.81 Billion | 3.09 Billion | 942.58 Million |
Cash at end of period | 1 Billion | 722.36 Million | 815.13 Million | 2.74 Billion | 2.74 Billion | 679.27 Million |
Capital Expenditure | -135.77 Million | -120.62 Million | -78.35 Million | -391.49 Million | -130.14 Million | -113.46 Million |
Effect of forex changes on cash | - | - | - | -798.78 Million | -494.61 Million | -0.08 |
Net cash flow / Change in cash | 281.3 Million | -92.77 Million | -5.9 Million | -1.07 Billion | -352.83 Million | -263.3 Million |
Free Cash Flow | -15.72 Million | -53.26 Million | 65.65 Million | -147.52 Million | -33.76 Million | -185.2 Million |
6535
003032
YURANUS
300758
ACRB
ELAN-B